-
- 抗原
- VEGF 165
- 蛋白类型
- Recombinant
-
宿主
- 大鼠
-
资源
- 大肠杆菌（E. Coli）
- 产品特性
- VEGF-A, glioma-derived endothelial cell mitogen, Vascular permeability factor (VPF)
- 纯化方法
- Vascular Endothelial Growth Factor-165 purity was determined to be greater than 97% as determined by HpLC, analysis by UV-Spectroscopy at 280nm, and by reducing and non-reducing SDS-pAGE.
- 内毒素水平
- Low endotoxin
-
VEGF 165 protein
宿主: 人 宿主: HEK-293 Cells Recombinant > 95% as determined by Tris-Bis PAGE,> 95% as determined by HPLC
VEGF 165 (AA 27-191) protein (His-Avi Tag,Biotin)宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE
VEGF 165 (AA 27-191) (Active) protein (His tag,AVI tag,Biotin)宿主: 人 宿主: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. Func Active
VEGF 165 (AA 27-191) protein (His-Avi Tag)宿主: 人 宿主: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE
VEGF 165 (AA 207-371) protein (His tag)宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant > 90 % by SDS - PAGE SDS
VEGF 165 protein宿主: 小鼠 宿主: 大肠杆菌（E. Coli） Recombinant
-
- 应用备注
-
Application Note: Endothelial Growth Factor-165 Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Endothelial Growth Factor-165 in immunological assays.
Other Performance Data: Endotoxin Level: Measured by kinetic LAL analysis and is typically ≤ 1 EU/μg protein. Biologic Activity: The activity is determined by the dose-dependent induced proliferation of Human umbilical vein endothelial cells (HUVECs) and is typically 4.0-8.0 ng/mL.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
-
Reconstitution Volume: 2 μL (2-20 μL)
Reconstitution Buffer: Restore with deionized water (or equivalent)
- 缓冲液
-
Buffer: 0.01 M Sodium Phosphate, pH 7.5
Stabilizer: None
- 储存液
- Without preservative
- 储存条件
- RT,4 °C,-20 °C
- 有效期
- 6 months
-
- 抗原
- VEGF 165
- 别名
- VEGF-165
-
You are here:
